Zika vaccines and immunogenic compositions, and methods of using the same

US11975062B2 · kind B2 · utility

Assignee

• Takeda Vaccines, Inc. · US

Inventors

• Jill A. Livengood · Fort Collins, US
• Hansi DEAN · Cambridge, US
• Htay Htay HAN · Cambridge, US
• Raman K. Rao · Palo Alto, US
• Jackie Marks · Cambridge, US
• Gary Dubin · Zürich, CH
• Laurence DE MOERLOOZE · Zürich, CH
• Hetal Patel · Libertyville, US
• Asae Shintani · Suita, JP
• Holli Giebler · Cambridge, US
• James Gifford · Somerville, US
• Mark Lyons · Cambridge, US
• Sushma Kommareddy · Cambridge, US
• Tatsuki Satou · Hikari, JP

Key dates

• Filing date: Nov 30, 2018
• Grant date: May 7, 2024
• Expiry date: Feb 11, 2039

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present disclosure relates to Zika virus vaccines and immunogenic compositions having one or more antigens from a Zika virus (e.g., a Zika virus clonal isolate, a non-human cell adapted Zika virus, etc.), and methods of treatments and uses thereof.